Enzychem Lifesciences Corporation (183490.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap130.15B
Enterprise Value127.15B
P/E Ratio-4.23
PEG Ratio-0.29
Price/Sales Ratio1.35
Price/Book Ratio0.52
Enterprise/Revenue1.21
Enterprise/EBITDA-7.06

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.29
Operating Margin-0.3
AD

Management Effectiveness

Return On Assets-0.11
Return On Equity-0.12

Income Statement

Revenue67.75B
Revenue/Share784.6
Gross Profit2.49B
EBITDA-15.13B
Net Income-18.13B
Diluted EPS-234.5

Balance Sheet

Total Cash103.3B
Total Cash/Share1,310.19
Total Debt5.7B
Total Debt/Equity0.04
Current Ratio13.61
Book Value Per Share1,902.55

Price History

52-Week Change-17.5
52-Week High1,766
52-Week Low937
Moving Average 50 Days1,204.26
Moving Average 200 Days1,151.43

Statistics

Average Volume757,194
Shares Outstanding84.64M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor6:1
Last Split DateAugust 17, 2022
AD